Learn more about the institute.
12.22.17 – KOMO 4 News
Seattle Children's just launched a new immunotherapy trial for kids who were out of options. That could include 6-year-old... cont.
12.15.17 – Daily Mirror UK
Last year, little Erin Cross spent Christmas in the hospital with her parents, surrounded by fairy lights as she endured... cont.
12.12.17 – MedPage Today
Abatacept (Orencia), an immunomodulatory drug approved for rheumatoid arthritis, dramatically reduced the incidence of acute... cont.
The drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients... cont.
The Brotman Baty Institute for Precision Medicine combines the research strengths and capabilities of UW Medicine, Fred... cont.
Phase 1 trial aims to increase long-term remission, it is the first on the West Coast to target CD22-positive leukemia
More Press Releases
Help us answer questions about childhood health and illness, and help other children in the future.
“What if?” Every day at Seattle Children’s Research Institute, we ask this simple two-word question.
Learn how our science is helping children live healthier, happier lives.